Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
11,938.08
+64.04
(+0.54%)
NZD/USD
0.5981
+0.0018
(+0.30%)
NZD/EUR
0.5563
+0.0007
(+0.12%)
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
OIL
78.94
-0.01
(-0.01%)
Clover Biopharmaceuticals, Ltd. (2197.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.435
+0.065
(+17.57%)
At close: 04:08PM HKT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
Currency in CNY.
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
257
0
0
0
Operating expenses
Research development
995,662
1,465,324
1,826,301
228,219
Selling general and administrative
105,831
113,070
160,582
76,429
Total operating expenses
1,302,980
1,861,152
2,157,785
284,289
Operating income or loss
-1,302,925
-1,861,152
-2,157,785
-284,289
Interest expense
15,502
5,930
2,520
1,657
Income before tax
-665,194
-2,451,903
-6,016,303
-912,898
Income tax expense
0
0
0
0
Income from continuing operations
-665,194
-2,451,903
-6,016,303
-912,898
Net income
-665,194
-2,451,903
-6,016,303
-912,898
Net income available to common shareholders
-665,194
-2,451,903
-6,016,303
-912,898
Basic EPS
-0.65
-2.22
-13.02
-0.79
Diluted EPS
-0.65
-2.22
-13.02
-0.79
Basic average shares
1,179,166
1,102,104
462,117
1,158,115
Diluted average shares
1,182,010
1,102,104
462,117
1,158,115
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.